NMG
GSK icon

New Millennium Group’s GSK GSK Stock Holding History

New Millennium Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$168K Buy
3,416
+1,940
+131% +$90.5K 0.07% 69
2025
Q3 		$63.7K Buy
+1,476
New +$57.7K 0.03% 101

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

New Millennium Group's GSK Position: Q4 2025 in Review

New Millennium Group increased its GSK (GSK) stake by 131% in Q4 2025, buying an estimated $90.5K and bringing the position to 3,416 shares worth $168K. The position accounts for 0.07% of the portfolio, ranked #69.

New Millennium Group first reported a position in GSK in Q3 2025 and has held it in 2 quarters since. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • New Millennium Group held 3,416 shares of GSK worth $168K as of Q4 2025.
  • New Millennium Group bought 1,940 GSK shares in Q4 2025, an estimated $90.5K.
  • GSK made up 0.07% of New Millennium Group's portfolio in Q4 2025, its #69 holding.
  • New Millennium Group first reported a position in GSK in Q3 2025 and has held it in 2 quarters since.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.